| Survival: | ? |
| Toxicity Grade: | 4 |
| Treatments: | Immunotherapy |
| Drugs: | |
| Country: | United States |
| City/State/Province: | Houston, Texas |
| Hospital: | Memorial Hermann Hospital |
| Journal: | Link |
| Date: | 12/2002 |
| Description: |
| Patients: This Phase I study involved 29 patients with a variety of different cancers. One patient had mesothelioma. Treatment: The treatment consisted of injections of recombinant human interleukin-12 (a protein). Toxicity: Toxicities for all patients included grade 4 lymphopenia, and grade 3 or less nausea, vomiting, fatigue, fever, infection, and abdominal pain. Results: Of 29 patients, two experienced complete response – the patient with mesothelioma is without progression at two years. Correspondence: Ralph S. Freedman, MD |